Josh helps entrepreneurs build their businesses and advises them on significant transactions in the life cycle of their companies, with a particular focus on fundraising transactions and exit events.
He represents founders, start-ups, and emerging companies, serving as general counsel to those start-ups and emerging companies. Josh advises clients regarding company formation and early-stage legal issues, a broad range of financings, including angel, venture capital, and strategic investments, and mergers and acquisitions. He also provides guidance on legal and business matters that arise in the daily operations of their businesses.
Josh typically works with companies in the life sciences industry — drug development, devices, diagnostics, and tools — and in the technology sector, including energy, digital health, software. He has helped numerous clients, including the following, to grow and thrive:
- Aquinnah Pharmaceuticals
- Asimov
- Axoft
- BLASTID
- Droplette
- Hopewell Therapeutics
- KiraGen Bio
- Limax Biosciences
- MediSix Therapeutics
- NanoView Biosciences
- NextGen Jane
- PanTher Therapeutics
- Quaise Energy
- Seven Starling
- Stemloop
- Syntis Bio
- Teal Bio
- Topo Therapeutics
In addition to counseling entrepreneurs and emerging companies, Josh represents venture capital firms, foundations, and other investors.
Josh frequently speaks about topics related to entrepreneurship, financing, exit strategies, and best practices for businesses. He has also been a lecturer at the Boston University School of Law, teaching a class on venture capital financings that he created.
Josh maintains an active pro bono practice and is involved in the firm’s operations, including hiring activities.
viewpoints
Checklist for Foreign Companies Expanding into the US
August 26, 2024 | Advisory | By Kaoru C. Suzuki, Larry P. Naughton, Joshua D. Fox
This article provides a checklist of action items for foreign companies making an initial expansion into the US, covering essential topics like choosing a business structure, navigating laws and regulations concerning immigration, employment, and taxes, and securing funding.
Energy & Sustainability Client Feature — Quaise
June 3, 2024 | Article | By Joshua D. Fox
Read about Quaise Energy, a trailblazer in the terawatt-scale geothermal energy space, and its recent $21 million Series A1 financing round, which will help Quaise accelerate its field operations and secure its supply chain.
Five Ways To Target Success As A Startup
July 11, 2023 | Article
Turning innovation into a successful business can be daunting. In a panel discussion at the BIO International Convention, Mintz’s Josh Fox, who is a Member in our Chambers-ranked Life Sciences practice, alongside Massachusetts Institute of Technology (MIT) professors Robert Langer, Angela Koehler, and Giovanni Traverso, examined the challenges associated with spinning out innovations from academic and research institutions, including how to build a team to run a new company and how to fund startups, particularly those that may not attract traditional venture capital easily (or at all). Here are their five key takeaways.
Energy & Sustainability Client Feature — Quaise Energy, Inc.
September 6, 2022 | Article | By Joshua D. Fox
Read about Quaise Energy, an energy company unlocking terawatt-scale geothermal energy by developing and utilizing millimeter-wave drilling systems, and the expansion of its Series A financing round from $40 million to $52 million.
For Second Consecutive Year, Mintz, Mergermarket Publish Life Sciences M&A Report
June 10, 2021 | Article
For the second consecutive year, Mintz, in partnership with Mergermarket, has produced a comprehensive report on recent M&A activity in the life sciences industry.
News & Press
Mintz announced today that 42 of its practices and 83 of its attorneys earned recognition in the 2024 edition of Chambers USA, a guide to the country’s leading law firms. Of those included in the guide, 18 attorneys and seven practice areas were awarded Chambers’ highest ranking, Band 1. The firm obtained new listings in three practice areas and 10 of its lawyers were recognized for the first time.
Mintz Advises Quaise Energy in $21M Series A1 Funding
March 14, 2024
CAMBRIDGE, Mass.—Mintz advised Quaise Energy, a developer of a new hybrid deep drilling technology for geothermal energy, in its recent $21 million Series A1 funding round. The deal brings Quaise’s total funding to more than $95 million. The investment will be used to scale up Quaise’s supply chain and enhance its field operations by improving geologic understanding at plant sites.
Harvard Law Grads Give Boston Cold Shoulder, Take Jobs Elsewhere
September 11, 2023
Bloomberg Law quoted Members Joshua Fox and Louis Mercedes, as well as Associate Aaron Fenton in an article analyzing potential reasons why Harvard Law graduates are accepting job offers outside of Massachusetts. Joshua, Lou, and Aaron discussed the benefits graduates have when staying local to the Boston area.
BOSTON – Mintz announced today that it advised Hopewell Therapeutics, a biotechnology company with a differentiated lipid nanoparticle platform harnessing unique ionizable lipid chemistry, in its Seed Financing of up to $25 million. The funds will enable Hopewell to advance the development of genomic medicines based on its differentiated tissue-targeted Lipid Nanoparticle (ttLNP) platform through both internal pipeline programs and external partnerships.
BOSTON –Mintz announced today that 39 of its practices and 81 of its attorneys earned recognition in the 2023 edition of Chambers USA, a guide to the country’s leading law firms.
Carta quoted Member Joshua Fox about the state of the venture capital environment and the creative solutions startups are leaning on to avoid a down round.
Mintz's sponsorship and involvement with the MassNextGen Initiative was highlighted in a press release issued by the Massachusetts Life Sciences Center.
Mintz To Support Life Sciences Start-Up Market Through Innovative Relationship With Nucleate Boston
February 20, 2023
BOSTON – Mintz has entered into an exclusive partnership with Nucleate Boston, providing the nonprofit organization with legal support for its 2023 Activator Program.
Biotech Startups, VCs Seek Path Forward After A Bruising Year
January 12, 2023
Mintz Member Joshua Fox spoke to the Wall Street Journal about what's ahead for biotech startups and venture capitalists following a difficult year.
Mintz Member Joshua Fox spoke to Forbes about the logistics of Shark Tank and how deal terms develop after filming.
Mintz Advises Bio Client Asimov in $200M Fundraising
January 10, 2023
Mintz advised Asimov in a $200 million fundraising aimed at helping the synthetic biology company scale its tools and services business focused on biologics, cell and gene therapies, and RNA. Mintz Member and seasoned life sciences transactional attorney Joshua Fox led a team that included Associates Kaoru Suzuki and Michael Katz.
Mintz Leads For Axoft In $8 Million Seed Round Demonstrating Continued Dedication To Biotech Start-Up Market
October 19, 2022
Mintz represented Axoft, a neurotechnology company, in its $8 million seed round led by The Engine, a venture firm spun out of MIT that invests in early-stage Tough Tech companies.
Mintz took lead role for long-term client NanoView Biosciences in its sale to Unchained Labs, a portfolio company of The Carlyle Group. NanoView, through its ExoView technology, characterizes exosomes and the company’s LentiView platform complements Unchained Labs’ tools for gene therapy researchers working with lentivirus, which is an immunodeficiency virus that causes AIDS.
Mintz, Mergermarket Publish Life Sciences M&A Report
June 24, 2020
The article noted that “Osborn and Fox are the latest hires in Mintz’s growing corporate practice, which also had two notable hires in March. The Boston-based firm is enjoying record revenue and profit highs after four straight years of growth.”
podcasts
Client Corner: Meet CEO and COO of Suono Bio, Scott Kellogg & Skip Farinha
March 1, 2024 | Podcast | By Joshua D. Fox
In this episode of Client Corner, Josh speaks to Suono Bio’s CEO Scott Kellogg and COO Skip Farinha. Scott and Skip discuss the importance of active listening in managing a team, strategies for navigating the medical device approval process in the US, key factors to consider when selecting investors, and insights on managing unforeseen challenges.
Client Corner: Meet Co-founder & CEO of Axoft, Paul Le Floch
February 16, 2024 | Podcast | By Joshua D. Fox
In this episode of Client Corner, Josh speaks to Paul Le Floch, Co-founder & CEO of Axoft. Paul discusses his journey from growing up in France to becoming a founder and the CEO of a neurotechnology startup. He provides insight into forming Axoft and navigating the fundraising process and offers advice to individuals starting new ventures.
Client Corner: Gio Traverso’s Journey Starting Biotech Companies
January 12, 2024 | Podcast | By Joshua D. Fox
In this episode of Client Corner, Josh speaks to Gio Traverso, MIT professor, founder of several biotech companies, and a physician. Gio discusses his experience starting six different companies with Josh, comprising both for-profit and nonprofit entities. He reflects upon the process of deciding whether to start a business using a nonprofit or a for-profit structure, bringing together a strong team, evaluating potential investors, and licensing intellectual property from a university.
Client Corner: Carlos Araque on Leading a Startup
December 15, 2023 | Podcast | By Joshua D. Fox
In this week’s episode of Client Corner, Josh speaks to Carlos Araque, Co-founder and CEO of Quaise Energy. Carlos discusses his motivation in developing Quaise Energy and his guiding philosophy of impact over probability of success. He provides advice to other first-time CEOs and offers insights on the state of diversity in the technology sector.
Client Corner: Anna Turetsky on Venture Investing
December 1, 2023 | Podcast | By Joshua D. Fox
In this week’s episode of Client Corner, Member and Host Josh Fox chats with Anna Turetsky, Principal, Venture Investments for the Mark Foundation for Cancer Research.
Client Corner: Meet Syntis Bio Co-founder and CEO Rahul Dhanda
November 10, 2023 | Podcast | By Joshua D. Fox
In this episode of Client Corner, Josh chats with Rahul Dhanda, co-founder and CEO of Syntis Bio, a late-stage, preclinical company developing a new class of therapy.
Client Corner: Meet Biotech Executive John Edwards
October 27, 2023 | Podcast | By Joshua D. Fox
In this episode of Client Corner, Josh chats with John Edwards, an executive chair, board member, and senior adviser to start-up and clinical-stage biotechnology companies.
Client Corner: Ridhi Tariyal, Co-founder & CEO of NextGen Jane
October 13, 2023 | Podcast | By Joshua D. Fox
In this episode of Client Corner, Member Josh Fox talks with NextGen Jane’s Co-founder and CEO, Ridhi Tariyal about how the company is using precision medicine to transform obstetric and gynecological care.
Client Corner: Jerry Williamson, CEO of Sengenics
September 29, 2023 | Podcast | By Joshua D. Fox
In this episode of Client Corner, Joshua Fox chats with Jerry Williamson, CEO of Sengenics. Jerry has more than 30 years of experience in bioscience markets for life science research, diagnostics, and analytical products.
Events & Speaking
After the Term Sheet
Harvard Law Entrepreneurship Project's Visionaries & Ventures Convention
Four Seasons Boston
Recognition & Awards
Chambers USA: Nationwide - Start Ups and Emerging Companies (2023-2024)
Chambers USA: Massachusetts- Private Equity: Venture Capital Investment (2024)
Boston Magazine: Top Lawyers – Corporate Law (2021)
Conservation Law Foundation, Legal Food Hub: Distinguished Service Award (2019)
The Legal 500 United States: Recommended for Finance: Capital Markets: Equity Offerings: Advice to Managers (2016)
Boston Magazine: New England Super Lawyers Rising Stars (2008, 2010 – 2016)
Boston Bar Association, Lawyers Committee for Civil Rights Under Law: Civil Rights Recognition Award (2010)
Phi Beta Kappa
Involvement
- Board of Directors, Lawyers for Civil Rights
- Past Member, Board of Visitors, D’Amore-McKim School of Business, Northeastern University
- Past President and Member, Board of Directors, Tufts Lawyers Association
- Past Mentor, BUILD
- Past Member, Leadership Council, Dana-Farber Cancer Institute
- Past Member, Alumni Council, Tufts University
Recent Insights
Checklist for Foreign Companies Expanding into the US
August 26, 2024| Advisory|
Mintz announced today that 42 of its practices and 83 of its attorneys earned recognition in the 2024 edition of Chambers USA, a guide to the country’s leading law firms. Of those included in the guide, 18 attorneys and seven practice areas were awarded Chambers’ highest ranking, Band 1. The firm obtained new listings in three practice areas and 10 of its lawyers were recognized for the first time.
